Skip to Main Content

Paper Details

Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.
Neurooncol Adv
3
2023
CNS WHO grade 2 meningioma, CNS WHO grade 2 meningiomas, brain tumors, meningiomas, methylation family, patients, tumor
Author NameAffiliation
Sybren L N MaasHeidelberg University Hospital and CCU Neuropathology, German Cancer Research Center (DKFZ)
Sybren L N MaasUniversity Medical Center Utrecht, Utrecht University
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ)
Stefan M PfisterUniversity Hospital Heidelberg
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterUniversity Hospital Heidelberg
Stefan M PfisterGerman Cancer Research Center (DKFZ)
Christine JungkUniversity Hospital Heidelberg
Andreas UnterbergUniversity Hospital Heidelberg
Andreas von DeimlingHeidelberg University Hospital and CCU Neuropathology, German Cancer Research Center (DKFZ)
Felix SahmHeidelberg University Hospital and CCU Neuropathology, German Cancer Research Center (DKFZ)
Felix SahmHopp Children's Cancer Center Heidelberg (KiTZ)
Felix SahmHeidelberg University Hospital and CCU Neuropathology, German Cancer Research Center (DKFZ)
Felix SahmHopp Children's Cancer Center Heidelberg (KiTZ)
  • 1 - 19

Datasets

Release 1.2